Immatics Appoints Biotech Executive Eliot Forster to Board of Directors
Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…
Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical Company active in the discovery and development of T-c…
Immatics Biotechnologies GmbH, a leading company in the field of cancer immunotherapy announces the appointment of Katin…
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that…
immatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing therapeutic vaccines that are activ…
immatics biotechnologies GmbH, a late-stage biopharmaceutical company developing therapeutic vaccines that are active ag…
GMG, the world's leading color management solutions provider, is pleased to announce that it will present solutions with…
immatics biotechnologies GmbH today announced the appointment of Dr Carsten Reinhardt as Chief Medical Officer (CMO) eff…
"There s nothing like starting young" - so goes the old German proverb. The truth of this saying is demonstrated by the…
DeveloGen AG, a biopharmaceutical company active in the discovery and development of novel therapeutic drugs for the tre…